Drug Shortage Report for TEVA-ECTOSONE

Last updated on 2022-03-24 History
Report ID 144715
Drug Identification Number 00653217
Brand name TEVA-ECTOSONE
Common or Proper name TEVA-ECTOSONE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE
Strength(s) 0.1%
Dosage form(s) LOTION
Route of administration TOPICAL TOPICAL
Packaging size 75
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-08-27
Estimated end date 2022-09-30
Actual end date
Shortage status Actual shortage
Updated date 2022-03-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-03-24 French Compare
v10 2022-03-24 English Compare
v9 2022-02-10 French Compare
v8 2022-02-10 English Compare
v7 2021-12-22 French Compare
v6 2021-12-22 English Compare
v5 2021-10-07 French Compare
v4 2021-10-07 English Compare
v3 2021-08-28 English Compare
v2 2021-08-27 French Compare
v1 2021-08-27 English Compare

Showing 1 to 11 of 11